C10orf97 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9H8M7 |
---|
Gene ID | 80013 |
---|---|
Other Names | Protein FAM188A, Dermal papilla-derived protein 5, Protein CARP, FAM188A, C10orf97, CARP, DERP5 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | MINDY3 (HGNC:23578) |
---|---|
Function | Hydrolase that can remove 'Lys-48'-linked conjugated ubiquitin from proteins. |
Cellular Location | Nucleus. |
Tissue Location | Widely expressed with high levels in heart, skeletal muscle, and kidney, and low levels in liver and brain (PubMed:12054670). Also expressed in lung (at protein level) (PubMed:21499297). |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
C10ORF97 is a member of the caspase-associated recruitment domain (CARD) family of proteins that play a role in apoptosis.
References
Meyre, D., et al. Nat. Genet. 41(2):157-159(2009)Daw, E.W., et al. Hum. Mol. Genet. 16(20):2463-2471(2007)Liu, B., et al. Biochem. Biophys. Res. Commun. 293(5):1396-1404(2002)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.